plasma kallikrein

Takeda Announces Approval of TAKHZYRO® (lanadelumab) subcutaneous injection in China for the Treatment of Hereditary Angioedema

Shanghai, China & Osaka, Japan:  − TAKHZYRO is the first approved modern therapy for the preventive treatment of hereditary angioedema…

Read More »